Focused Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Focused Wealth Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14	Closed	-$1.12K	–	1085
2023 Q3	$1.12K	Hold	14	–	–	﹤0.01%	838
2023 Q2	$1.1K	Hold	14	–	–	﹤0.01%	871
2023 Q1	$1.09K	Sell	14 -50	-78%	-$3.85K	﹤0.01%	858
2022 Q4	$4.98K	Buy	+64	New	+$4.72K	﹤0.01%	652
2021 Q1	–	Sell	-222	Closed	-$15K	–	986
2020 Q4	$15K	Buy	+222	New	+$14.2K	﹤0.01%	514

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Focused Wealth Management's PPH Position: Q4 2023 in Review

Focused Wealth Management sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2023, closing a stake of 14 shares — an estimated $1.12K sold.

Focused Wealth Management first reported a position in PPH in Q4 2020 and held it in 5 quarters. The position peaked at $15K in Q4 2020. 110 funds tracked by Wall St. Rank hold PPH as of Q4 2023.

Focused Wealth Management reported no remaining VanEck Pharmaceutical ETF position as of Q4 2023 after selling out during the quarter.
Focused Wealth Management sold 14 VanEck Pharmaceutical ETF shares in Q4 2023, an estimated $1.12K.
Focused Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q4 2020 and held it in 5 quarters.
Focused Wealth Management's VanEck Pharmaceutical ETF position peaked at $15K in Q4 2020.
110 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2023.

Based on Focused Wealth Management's 13F filing for Q4 2023, filed 10 Jan 2024.